文献速递前列腺增生与排尿功能障碍

自体阴道壁吊带治疗压力性尿失禁的超长期随访:23年结果

Ultra Long-term Follow-up of the Autologous Pubovaginal Sling for Stress Incontinence: Results at 23 Years.
PubMed 文献 · Urology · 2023-12-13

分析1993至1999年接受自体阴道壁吊带术的192例女性压力性尿失禁患者,在平均4年和23年随访时,51例有充分数据的患者中分别有96%和84%报告无压力性尿失禁,总体干爽率分别为84%和53%。作者认为该术式在平均23年时有效、安全且持久,并建议将其作为寻求治疗女性的一个选择。

要点

  • 中期随访(平均45.3个月)51例中96%无压力性尿失禁,84%总体干爽。
  • 超长期随访(平均22.9年)51例中84%无压力性尿失禁,总体干爽率53%。
  • 术后排尿功能障碍包括新发急迫性尿失禁3例和持续梗阻需尿道松解术1例。

核心结论

  • 作者认为自体阴道壁吊带在平均23年时有效、安全且持久,为文献中最长随访。
  • 鉴于美国食品药品监督管理局(FDA)对经阴道网片的警告及对合成中段尿道吊带日益增加的担忧,作者认为应向寻求压力性尿失禁治疗的女性提供自体阴道壁吊带作为选项。

研究设计与样本

  • 分析1993年至1999年连续192例接受自体阴道壁吊带术的女性压力性尿失禁患者,随访期29年。
  • 中期和超长期随访分别在平均4年和23年时获得。
  • 51例患者在两个时间点均有充分数据,采用标准化问卷评估压力性尿失禁缓解(主要终点)、急迫性尿失禁缓解、总体干爽及排尿功能障碍。

主要发现

  • 中期随访(平均45.3个月)51例中96%报告无压力性尿失禁。
  • 中期随访中76%患者术前急迫性尿失禁缓解,总体干爽率84%。
  • 超长期随访(平均22.9年)51例中84%报告无压力性尿失禁,总体干爽率53%。
  • 术后排尿功能障碍包括新发急迫性尿失禁3例和持续尿路梗阻需尿道松解术1例。

临床怎么用

  • 作者认为,鉴于FDA对经阴道网片的警告及对合成中段尿道吊带的日益担忧,应向寻求压力性尿失禁治疗的女性提供自体阴道壁吊带作为选项。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the efficacy, safety, and long-term durability of the autologous pubovaginal sling for stress incontinence over a 29-year period. METHODS: A total of 192 consecutive female patients with stress urinary incontinence who underwent autologous pubovaginal sling from 1993 through 1999 were analyzed over a 29-year period. Intermediate and ultra long-term follow-up were obtained at a mean of 4 and 23 years, respectively. A total of 51 patients had sufficient data at both time intervals and were evaluated using a standardized questionnaire for resolution of stress incontinence, the primary endpoint, as well as resolution of urge incontinence, overall dryness, and voiding dysfunction. RESULTS: At intermediate-term follow-up (mean 45.3 months), 96% of 51 patients reported no stress incontinence. In addition, 76% of patients experienced resolution of their preoperative urge incontinence. Overall dryness occurred in 84%. At ultra long-term follow-up (mean 22.9 years), 84% reported no stress incontinence and an overall dryness rate of 53%. Postoperative voiding dysfunction included de novo urge incontinence (3 patients) and persistent urinary obstruction requiring urethrolysis (1 patient). CONCLUSION: The autologous pubovaginal sling is effective, safe, and durable at a mean of 23 years, the longest known follow-up in the literature. Given the U.S. Food and Drug Administration (FDA) warnings regarding transvaginal mesh and growing concerns with the synthetic midurethral sling, the autologous pubovaginal sling should be offered as an option to those women seeking treatment for stress urinary incontinence.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Zaragoza MR, Moorman M, Chew L, et al. Ultra Long-term Follow-up of the Autologous Pubovaginal Sling for Stress Incontinence: Results at 23 Years. Urology. 2023. PMID: 38101581. doi:10.1016/j.urology.2023.12.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。